Almitrine + Raubasine


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : PO Auditory, vestibular and visual disorders of ischaemic aetiology; Cerebrovascular insufficiency; Functional rehabilitation after cerebrovascular accidents Per tab contains almitrine 30 mg and raubasine 10 mg: 1 tab twice daily.
Dosage Details
Oral
Auditory, vestibular and visual disorders of ischaemic aetiology, Cerebrovascular insufficiency, Functional rehabilitation after cerebrovascular accidents
Adult: Each tablet contains almitrine 30 mg and raubasine 10 mg. Recommended dosage: 1 tablet bid.
Contraindications
Concurrent usage with MAOIs.
Special Precautions
Pregnancy. Long term treatment may result in numbness, prickling or formication effects in the lower limbs which may, in rare cases, lead to treatment withdrawal.
Adverse Reactions
Mild GI disorders, sleep disturbances, palpitations, anxiety, dizziness. Rarely, wt loss, peripheral neuropathy with abnormal sensations in the lower limbs.
Overdosage
Signs include tachycardia, arterial hypotension, polypnoea and respiratory alkalosis. Treatment consists of gastric lavage and symptomatic supportive measures. Cardiopulmonary observation with repeated monitoring of blood gases are recommended.
Drug Interactions
Not to be used concurrently with other almitrine-containing preparations.
Potentially Fatal: MAOIs.
Action
Description: Almitrine and raubasine work together to increase the amount of oxygen brought to the brain and neurosensory tissue, by increasing the oxygen content of arterial blood.
Disclaimer: This information is independently developed by MIMS based on Almitrine + Raubasine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in